Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,644.00p
   
  • Change Today:
    -42.00p
  • 52 Week High: 2,354.00
  • 52 Week Low: 1,630.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 67,225
  • Market Cap: £1,085.61m
  • RiskGrade: 128
  • Beta: 1.51

Latest ShareCast News

London close: Stocks fall as UK inflation tops BoE targets

By Josh White

Date: Wednesday 20 Nov 2024

(Sharecast News) - London stocks ended Wednesday in negative territory as unexpectedly high UK inflation data dampened hopes of an imminent interest rate cut by the Bank of England.

Genus reports encouraging start to financial year

By Josh White

Date: Wednesday 20 Nov 2024

(Sharecast News) - Animal genetics specialist Genus reported an encouraging start to its 2025 financial year on Wednesday, with trading in line with market expectations despite an anticipated currency headwind of £8m to £9m.

London close: Stocks mixed as government borrowing rises

By Josh White

Date: Tuesday 22 Oct 2024

(Sharecast News) - London stocks saw a mixed performance on Tuesday, with investors digesting the latest data on government borrowing ahead of next week's Budget.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,644.00p
Change Today -42.00p
% Change -2.49 %
52 Week High 2,354.00
52 Week Low 1,630.00
Volume 67,225
Shares Issued 66.03m
Market Cap £1,085.61m
Beta 1.51
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Trend Not Available
Income
77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 07-Nov-24 29-Feb-24
Paid 06-Dec-24 28-Mar-24
Amount 21.70p 10.30p

Trades for 21-Nov-2024

Time Volume / Share Price
15:52 0 @ 1,654.00p
16:28 38 @ 1,646.00p
16:28 13 @ 1,646.00p
16:28 15 @ 1,646.00p
16:28 34 @ 1,644.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page